Economic evaluation of temsirolimus on the basis of the results of the ARCC (Advanced Renal-Cell Carcinoma) study. FE [Internet]. 2009 Jun. 15 [cited 2025 Dec. 29];10(2):93-7. Available from: https://journals.seedstm.com/index.php/FE/article/view/167